Dupont Jakob

CIK 00015533356 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001553335

Recent Transactions

50 trades

Award
Pyxis Oncology, Inc.$PYXS
Stock Option (Right to Buy)
2026-03-24+45,867→ 45,867 total
Disposition to Issuer
Bolt Biotherapeutics, Inc.$BOLT
Director Stock Option (Right to Buy)
2025-12-12−1,100→ 0 total
Award
Bolt Biotherapeutics, Inc.$BOLT
Director Stock Option (Right to Buy)
2025-12-12+1,100→ 1,100 total
Disposition to Issuer
Bolt Biotherapeutics, Inc.$BOLT
Director Stock Option (Right to Buy)
2025-12-12−1,000→ 0 total
Award
Bolt Biotherapeutics, Inc.$BOLT
Director Stock Option (Right to Buy)
2025-12-12+849→ 849 total
Disposition to Issuer
Bolt Biotherapeutics, Inc.$BOLT
Director Stock Option (Right to Buy)
2025-12-12−2,500→ 0 total
Award
Bolt Biotherapeutics, Inc.$BOLT
Director Stock Option (Right to Buy)
2025-12-12+2,500→ 2,500 total
Award
Bolt Biotherapeutics, Inc.$BOLT
Director Stock Option (Right to Buy)
2025-12-12+1,000→ 1,000 total
Disposition to Issuer
Bolt Biotherapeutics, Inc.$BOLT
Director Stock Option (Right to Buy)
2025-12-12−849→ 0 total
Award
Bolt Biotherapeutics, Inc.$BOLT
Stock Option (Right to Buy)
2025-05-27+1,100→ 1,100 total
Award
Bolt Biotherapeutics, Inc.$BOLT
Stock Option (Right to Buy)
2025-05-01+20,000→ 20,000 total
Award
Pyxis Oncology, Inc.$PYXS
Stock Option (Right to Buy)
2025-03-31$0.98/sh+36,979→ 36,979 total
Award
Bolt Biotherapeutics, Inc.$BOLT
Stock Option (Right to Buy)
2024-09-03+50,000→ 50,000 total
Award
Bolt Biotherapeutics, Inc.$BOLT
Stock Option (Right to Buy)
2024-09-03+16,984→ 16,984 total
Award
Pyxis Oncology, Inc.$PYXS
Common Stock
2024-03-26+38,741→ 38,741 total
Award
Pyxis Oncology, Inc.$PYXS
Stock Option (Right to Buy)
2023-09-22+392,461→ 392,461 total
Disposition to Issuer
Apexigen, Inc.
Stock Option (right to buy)
2023-08-23−34,084→ 0 total
Award
Pyxis Oncology, Inc.$PYXS
Stock Option (Right to buy)
2023-08-23+3,534→ 3,534 total
Award
Pyxis Oncology, Inc.$PYXS
Stock Option (Right to buy)
2023-08-23+5,879→ 5,879 total
Award
Pyxis Oncology, Inc.$PYXS
Stock Option (Right to buy)
2023-08-23+17,250→ 17,250 total
Disposition to Issuer
Apexigen, Inc.
Stock Option (right to buy)
2023-08-23−100,000→ 0 total
Disposition to Issuer
Apexigen, Inc.
Stock Option (right to buy)
2023-08-23−20,489→ 0 total
Sale
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2023-03-02$3.63/sh−5,074→ 290,794 total
Award
Atara Biotherapeutics, Inc.$ATRA
Employee Stock Option (Right to Buy)
2023-03-01+317,987→ 317,987 total
Award
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2023-03-01+141,328→ 295,868 total
Sale
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2022-11-16$4.49/sh−3,218→ 155,664 total
Sale
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2022-11-16$4.49/sh−1,124→ 154,540 total
Award
Apexigen, Inc.
Stock Option (right to buy)
2022-09-29+100,000→ 100,000 total
Sale
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2022-08-16$5.03/sh−4,124→ 158,882 total
Sale
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2022-05-17$5.32/sh−3,873→ 163,006 total
Sale
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2022-03-01$9.86/sh−2,221→ 166,879 total
Award
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2022-03-01+78,506→ 169,100 total
Award
Atara Biotherapeutics, Inc.$ATRA
Employee Stock Option (Right to Buy)
2022-03-01+147,573→ 147,573 total
Sale
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2022-02-10$16.00/sh−5,000→ 90,594 total
Exercise/Conversion
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2022-02-10$9.58/sh+5,000→ 95,594 total
Exercise/Conversion
Atara Biotherapeutics, Inc.$ATRA
Employee Stock Option (Right to Buy)
2022-02-10−5,000→ 257,500 total
Sale
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2022-01-03$16.01/sh−5,000→ 90,594 total
Exercise/Conversion
Atara Biotherapeutics, Inc.$ATRA
Employee Stock Option (Right to Buy)
2022-01-03−5,000→ 262,500 total
Exercise/Conversion
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2022-01-03$9.58/sh+5,000→ 95,594 total
Sale
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2021-12-01$17.94/sh−5,000→ 90,594 total
Exercise/Conversion
Atara Biotherapeutics, Inc.$ATRA
Employee Stock Option (Right to Buy)
2021-12-01−5,000→ 267,500 total
Exercise/Conversion
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2021-12-01$9.58/sh+5,000→ 95,594 total
Sale
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2021-11-16$17.12/sh−2,199→ 90,594 total
Exercise/Conversion
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2021-11-02$9.58/sh+5,000→ 97,793 total
Sale
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2021-11-02$16.41/sh−5,000→ 92,793 total
Exercise/Conversion
Atara Biotherapeutics, Inc.$ATRA
Employee Stock Option (Right to Buy)
2021-11-02−5,000→ 272,500 total
Sale
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2021-08-17$12.53/sh−2,152→ 92,793 total
Sale
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2021-05-18$14.55/sh−5,184→ 94,945 total
Award
Atara Biotherapeutics, Inc.$ATRA
Employee Stock Option (Right to Buy)
2021-03-01+81,327→ 81,327 total
Award
Atara Biotherapeutics, Inc.$ATRA
Common Stock
2021-03-01+53,879→ 100,129 total

Companies

Recent Filings

Address

C/O PYXIS ONCOLOGY, INC. 321 HARRISON AVENUE, 11TH FL. SUITE 1

BOSTON, MA, 02118

View on SEC.gov